At Pack Expo 2026, IMA Group will showcase its latest innovations in processing, packaging, end-of-line, automation, as well ...

A Cochrane review of 93 studies has linked pharmaceutical industry promotional activities with less appropriate prescribing ...

The UK biotech's Doggybone DNA platform won the Innovation Catalyst category at CPHI Milan 2026, recognising its potential to ...

The company has agreed to acquire New York-based Kinentia Biosciences, expanding its US presence and combining Kinentia’s ...

Biotech Fluidics announce SPEedy - a device that provides an effortless way to perform Solid Phase Extraction (SPE) sample ...

Long-standing joint venture partners expand collaboration, moving beyond anti-infective APIs into diversified therapeutic areas, including cardiovascular and oncology ...

Anton Paar introduces the new UNHT Series, a new generation of nanoindentation systems designed to deliver reliable results, ...

The UK's advertising watchdog has ruled against several companies advertising oral GLP-1 weight loss medications to the UK ...

For sponsors, development activities and fragmented clinical supply can slow the path from candidate selection to ...

Piramal Pharma Solutions (PPS) is to invest more than $5.3m in upgrading its drug substance manufacturing site in Aurora, ...

Learn why early notified-body engagement is critical for combination products, including design rationale, risk controls, validation evidence and traceable documentation ahead of submission.

The accelerated pathway extends the CDMO's Rapid Antibody framework to bispecifics and next-generation formats — targeting ...